m+Medelevator.RU
← Поиск публикаций
Menopause (New York, N.Y.) · 2026

Eight-session manualized cognitive behavioral therapy for anxiety and depression symptoms in perimenopause and postmenopause: a pilot study.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Hantsoo Liisa, Friedman-Wheeler Dara G, Lofland Gabriela, Harrison Sofia A, Smith Gwenn, Shen Wen

Аннотация

OBJECTIVE: Mood and anxiety symptoms at the menopause transition are common. However, most cognitive-behavioral treatments focused on perimenopause center on managing physical symptoms such as hot flashes, and not mood symptoms. In this case series, we assessed the impact of a CBT intervention program on anxiety and depressive symptoms among individuals in perimenopause or postmenopause, who reported mood symptoms.

METHODS: The intervention included eight 45-minute sessions of individual CBT with a clinical psychologist, and included CBT skills training (eg, behavioral activation, reframing negative automatic thoughts). The intervention was a general CBT intervention not tailored to perimenopause. Chart abstractions were performed for individuals who completed at least one session of the CBT program.

RESULTS: Twenty participants completed at least one session, and sixteen completed all eight sessions. Symptoms of depression (Patient Health Questionnaire 9 scores) decreased by 42.1% from session 1 ( M =8.74 [5.48]) to session 8 ( M =5.06 [4.77]) ( t =3.98, P =0.001). Similarly, symptoms of anxiety (GAD-7 scores) decreased by 56.2% from session 1 ( M =6.98 [4.38]) to session 8 ( M =3.06 [4.34]) ( t =3.39, P =0.004).

CONCLUSIONS: A standardized CBT intervention, not tailored to perimenopause, reduced depressive and anxiety symptoms in a small case cohort of women in perimenopause and postmenopause. Further research in a larger sample with a clinical trial design is needed.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты